5-Hydroxy-2-methyl-2,3,4,5-tetrahydrooxecin-10-one

Details

Top
Internal ID d6aa5ced-6ba7-4d2d-a6a1-3f3a00e2c160
Taxonomy Organoheterocyclic compounds > Oxocins
IUPAC Name 5-hydroxy-2-methyl-2,3,4,5-tetrahydrooxecin-10-one
SMILES (Canonical) CC1CCC(C=CC=CC(=O)O1)O
SMILES (Isomeric) CC1CCC(C=CC=CC(=O)O1)O
InChI InChI=1S/C10H14O3/c1-8-6-7-9(11)4-2-3-5-10(12)13-8/h2-5,8-9,11H,6-7H2,1H3
InChI Key SEURXENDYJJSDO-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H14O3
Molecular Weight 182.22 g/mol
Exact Mass 182.094294304 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 1.50
Atomic LogP (AlogP) 1.19
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 5-Hydroxy-2-methyl-2,3,4,5-tetrahydrooxecin-10-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9960 99.60%
Caco-2 + 0.7197 71.97%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.5672 56.72%
OATP2B1 inhibitior - 0.8644 86.44%
OATP1B1 inhibitior + 0.9266 92.66%
OATP1B3 inhibitior + 0.9635 96.35%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9669 96.69%
P-glycoprotein inhibitior - 0.9857 98.57%
P-glycoprotein substrate - 0.9370 93.70%
CYP3A4 substrate - 0.5177 51.77%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8873 88.73%
CYP3A4 inhibition - 0.9318 93.18%
CYP2C9 inhibition - 0.9687 96.87%
CYP2C19 inhibition - 0.9122 91.22%
CYP2D6 inhibition - 0.9603 96.03%
CYP1A2 inhibition - 0.6391 63.91%
CYP2C8 inhibition - 0.9846 98.46%
CYP inhibitory promiscuity - 0.9878 98.78%
UGT catelyzed + 0.5362 53.62%
Carcinogenicity (binary) - 0.8528 85.28%
Carcinogenicity (trinary) Non-required 0.6086 60.86%
Eye corrosion + 0.5131 51.31%
Eye irritation - 0.5177 51.77%
Skin irritation + 0.7544 75.44%
Skin corrosion + 0.5426 54.26%
Ames mutagenesis - 0.6500 65.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7309 73.09%
Micronuclear - 0.8800 88.00%
Hepatotoxicity + 0.5533 55.33%
skin sensitisation - 0.5642 56.42%
Respiratory toxicity + 0.5556 55.56%
Reproductive toxicity - 0.5719 57.19%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity - 0.6246 62.46%
Acute Oral Toxicity (c) III 0.5516 55.16%
Estrogen receptor binding - 0.9351 93.51%
Androgen receptor binding - 0.8784 87.84%
Thyroid receptor binding - 0.8723 87.23%
Glucocorticoid receptor binding - 0.8160 81.60%
Aromatase binding - 0.8906 89.06%
PPAR gamma - 0.9032 90.32%
Honey bee toxicity - 0.9386 93.86%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity - 0.5413 54.13%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 91.18% 83.82%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.13% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.43% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.45% 96.09%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 86.36% 86.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.44% 100.00%
CHEMBL2581 P07339 Cathepsin D 84.91% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.68% 99.23%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.95% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.75% 97.09%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Cirsium arvense

Cross-Links

Top
PubChem 123863605
LOTUS LTS0241406
wikiData Q104197228